A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA
2011/03/22 by Florence Campeotto, Antonia Suau, Nathalie Kapel +11 · 27 citations
Nursing · Health Professions · #Infant Nutrition and Health #Pediatric health and respiratory diseases #Child Nutrition and Water Access
paper · pdf · doi:10.1017/s0007114510005702
Abstract
Intestinal bacterial colonisation in pre-term infants is delayed compared with full-term infants, leading to an increased risk of gastrointestinal disease. Modulation of colonisation through dietary supplementation with probiotics or prebiotics could decrease such a risk. The present study evaluated clinical tolerance, the effects on gut microbiota, and inflammatory and immunological mucosal responses to an infant formula adapted for pre-term infants that included in its manufacturing process a fermentation step with two probiotic strains, Bifidobacterium breve C50 and Streptococcus thermophilus 065, inactivated by heat at the end of the process. A total of fifty-eight infants (gestational age: 30-35 weeks), fed either the fermented pre-term formula or a standard pre-term formula, were followed up during their hospital stay. Clinical tolerance, faecal microbiota using a culture and a culture-independent method (temporal temperature gel electrophoresis), faecal calprotectin and secretory IgA were analysed weekly. No difference was observed regarding anthropometric data and digestive tolerance, except for abdominal distension, the incidence of which was lower in infants fed the fermented formula for 2 weeks. Bacterial colonisation was not modified by the type of feeding, particularly for bifidobacteria. Faecal calprotectin was significantly lower in infants fed the fermented formula for 2 weeks, and secretory IgA increased with both mother's milk and the fermented formula. The fermented formula was well tolerated and did not significantly modulate the bacterial colonisation but had benefits on inflammatory and immune markers, which might be related to some features of gastrointestinal tolerance.
Cited by
- The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
- The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
- Branched chain fatty acids reduce the incidence of necrotizing enterocolitis and alter gastrointestinal microbial ecology in a neonatal rat model. [europepmc]
- Influence of gut microbiota on subclinical inflammation and insulin resistance. [europepmc]
- Food derived bioactive peptides and intestinal barrier function. [europepmc]
- Inclusion of fermented foods in food guides around the world. [europepmc]
- Preventive Effect of Cow's Milk Fermented with Lactobacillus paracasei CBA L74 on Common Infectious Diseases in Children: A Multicenter Randomized Controlled Trial. [europepmc]
- Specific Signatures of the Gut Microbiota and Increased Levels of Butyrate in Children Treated with Fermented Cow's Milk Containing Heat-Killed Lactobacillus paracasei CBA L74. [europepmc]
- Probiotic Supplementation in Preterm: Feeding Intolerance and Hospital Cost. [europepmc]
- Systematic Review of the Effect of Enteral Feeding on Gut Microbiota in Preterm Infants. [europepmc]
- Presence of Segmented Filamentous Bacteria in Human Children and Its Potential Role in the Modulation of Human Gut Immunity. [europepmc]
- Dietary modifications for infantile colic. [europepmc]
- Effects of prebiotics on sepsis, necrotizing enterocolitis, mortality, feeding intolerance, time to full enteral feeding, length of hospital stay, and stool frequency in preterm infants: a meta-analysis. [europepmc]
- Prevention of Rotavirus Diarrhea in Suckling Rats by a Specific Fermented Milk Concentrate with Prebiotic Mixture. [europepmc]
- Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. [europepmc]
- Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial. [europepmc]
- Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond. [europepmc]
- Postbiotics for Preventing and Treating Common Infectious Diseases in Children: A Systematic Review. [europepmc]
- Infant Formula Supplemented with Biotics: Current Knowledge and Future Perspectives. [europepmc]
- Postbiotics against Pathogens Commonly Involved in Pediatric Infectious Diseases. [europepmc]
- The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. [europepmc]
- The bacterial gut microbiome of probiotic-treated very-preterm infants: changes from admission to discharge. [europepmc]
- Term Infant Formulas Influencing Gut Microbiota: An Overview. [europepmc]
- The Concept of Postbiotics. [europepmc]
- Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics. [europepmc]
- Early gut microbiota intervention in premature infants: Application perspectives. [europepmc]
- Postbiotic production: harnessing the power of microbial metabolites for health applications. [europepmc]
Related